의료용 나노소재 연구실

Biomedical Nanomaterials Lab (BNL) is Prof. Sei Kwang Hahn’s laboratory in the Department of Materials Science and Engineering (DMSE) at the world class research university, POSTECH. BNL is working for smart biomaterials to develop nanomedicines including biosensors, bio-imaging systems, drug delivery systems, regenerative medicines and healthcare wearable devices. Prof. Hahn published more than 130 journal papers including Nature Reviews Materials, Nature Photonics, Nature Communications, Science Advances, Progress in Polymer Science, Advanced Materials, and ACS Nano, and filed more than 120 Korean and international patents. He is one of the Editorial Board Members for Biomacromolecules (American Chemical Society), ACS Biomaterials Science and Engineering, and Applied Sciences, and the Associate Editor of  Biomaterials Research. He won the Korean President Award in 2015, the Minister of Health & Welfare Award in 2017, and the Korean Minister of Education Award in 2013. He was a visiting professor at the Harvard Medical School in 2012. He is a member of National Science and Technology Council. BNL has greatly contributed to the successful commercialization of SR-hGH (Declage) in collaboration with LG Lifesciences, artificial bone graft (BonePlus) with MegaGen, post-surgical adhesion prevention solution (Medicurtain) with ShinPoong Pharmaceuticals and EGF cosmedicals (PHI-EGF) with PHI BioMed. Recently, BNL has developed smart contact lenses for ubiquitous healthcare supported by the Samsung Futuristic Technology Foundation. Prof. Hahn worked as a consultant for Johnson & Johnson in New Jersey and made a collaboration contract with Hoffman-La Roche. He is the CEO of a bio-venture company of “PHI BioMed” founded in 2014 and the Outside Director of KISWIRE. He was a member